Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Chlorella Market Worth $412.3 Million by 2028 – Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Meticulous Research®

Published

on

Redding,  California, Oct. 19, 2021 (GLOBE NEWSWIRE) — According to a new market research report titled “Chlorella Market by Technology (Open Pond), Product Type (Extract, Capsules), Source (Chlorella Vulgaris, Chlorella Pyrenoidosa or Sorokiniana), Application (Nutraceutical, Food and Beverages, Animal Feed), Geography– Global Forecast to 2028,” published by Meticulous Research®, the chlorella market is expected to reach $412.3 million by 2028, at a CAGR of 6.3% during the forecast period of 2021 to 2028. The growth of this market is mainly attributed to key factors such as the growing inclination of consumers toward a protein-rich diet, increasing health and wellness trends, development of innovative chlorella food and beverages products, growing nutraceutical industry, and growing vegetarianism across the globe. Moreover, the emergence of a new product: chlorella extracts, provides lucrative opportunities for players operating in this market.

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5162

Consumers are increasingly focused on living longer and healthier. Their preferences have shifted towards eating more natural, free from additives or preservatives, and organic food. Also, well-being is becoming nothing short of a global movement, as consumers seek to ensure healthy lives for as long as possible, particularly as average lifespans continue to rise.

Chlorella is a type of algae that packs a big nutrient punch, as it is a good source of several vitamins, minerals, and antioxidants. Emerging research shows that it could help shuttle toxins out of the body and improve cholesterol and blood sugar levels, among other health benefits. Further, rapid diets and lifestyles have occurred with industrialization, urbanization, economic development, and globalization. This is having a significant impact on populations’ health and nutritional status, particularly in developing countries.

In addition, the aging global population, rising chronic disease rates, rising in self-care, treatment & prevention, and increasingly educated & connected consumer trends are contributing to an increased focus on health and wellness. Consumers are also focusing on simplicity and transparency. Globally, the top three most appealing claims or descriptions are natural/all-natural, no artificial ingredients, and low or reduced fat/sugar/salt.

Advertisement
Stake.com

Besides, growing health awareness has increased demand for food products that support better health, especially low-fat, cholesterol, protein-rich, and weight control products. As a result, the number of food products containing plant-based proteins has grown distinctly in recent years. Also, all-natural and clean label trends within the F&B market are expected to increase the demand for natural ingredients, such as plant-based proteins, to produce natural and clean label products.

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5162

As the global trend for healthy and convenient food products continues, there is an opportunity for chlorella to be used in products with natural health claims, such as GMO-free, organic, and no additives. Since chlorella is high in protein and other essential nutrients, such as antioxidants, chlorophyll, vitamins, minerals, and fiber, changing food preferences and increasing health consciousness among consumers will positively impact the growth of the market.

Impact of COVID-19 on the Chlorella Market

The chlorella market is experiencing a positive impact mainly due to its key role in the immune health system. Chlorella is used as a healthy, natural, and sustainable superfood, which is in demand during COVID-19. During the pandemic, consumers demanded more food or ingredients which strengthen the immune and digestive system. For this reason, microalgae/algae have been one of the superfoods trends in Europe. The microalgae chlorella is rich in nutrients and bio compounds that are key factors in detoxifying, antioxidant, and immunity activity.

Advertisement
Stake.com

However, F&B companies across the world have felt the impact of COVID-19. Social distancing, self-isolation, and city-wide lockdowns forced many establishments to close in countries across Asia, the U.S., and Europe. In the U.K., the U.S., and Australia, supermarket chains have started to enforce new rules to curb panic buying, while suppliers and factory workers have put additional health and safety measures in place to keep consumers safe. Moreover, manufacturers of consumer food & beverage products have also faced significantly reduced consumption and disrupted supply chains. The food & beverage industry has witnessed a slight downfall due to the lockdowns imposed across various countries. All these factors somehow restricted the demand for chlorella in the market.

In addition, various government bodies have passed various rules and regulations for the purchase of essential goods. For instance, Singapore’s clampdown on products that claim to have COVID-19 health claims. South Korea’s Ministry of Food and Drug Safety announced that it would re-evaluate the safety and functionality of 12 functional raw materials in 2020. Also, the Taiwan Food and Drug Administration introduced new labeling rules for special medical foods. Further, according to trade organizations in the nutritional products industry, there is a significant impact on many points in the global supply chain for functional foods and dietary supplements. This will result in a slowdown in the sales and consumption of chlorella by its end users, impacting the chlorella market. Thus, the negative impact on the global economy, supply chains, and trade indirectly hampered the chlorella market’s growth to some extent.

Quick Buy – Chlorella Market Research Report: https://www.meticulousresearch.com/Checkout/18892773

Key Findings in the Chlorella Market Study:

Based on the technology, the heterotrophic segment is expected to grow with the fastest CAGR during the forecast period. The fast growth of this segment is primarily attributed to major factors such as higher productivity, lower risk of contamination, low water consumption, low space usage, and excellent purity of biomass. Further, its use to obtain higher cell concentration and products that are more suitable for the production of pure pharmaceuticals, nutraceuticals, and cosmetics are driving the demand for heterotrophic technology in the market.

Advertisement
Stake.com

However, the construction, maintenance, and operation costs of the heterotrophic systems are considerably higher, which is one of the major factors restricting the growth of this segment. Moreover, the autotrophic segment is expected to command the largest share of the overall chlorella market in 2021. The dominant position of this segment is mainly attributed to factors such as easy construction & management of open ponds, an cost-effective method for the production of large-scale biomass production, and more exposure of the culture to sunlight. Besides, the production of chlorella in open ponds by major chlorella-producing countries, such as Germany, Japan, China, the Czech Republic, and Taiwan, is expected to boost the production of chlorella by open pond technology.

Based on product type, the powder segment is expected to command the largest share of the overall chlorella market in 2021. The large share of this segment is mainly attributed to its strong coloring ability, growing number of health-conscious customers, and ability of chlorella powder to get rid of heavy metal and ash content like mercury from the body. Further, the large use of chlorella powder in the chlorella tablets, chlorella capsules, extracts, instant noodles, dumplings, bakery, beverages, ice cream, and dietary supplements, etc. drives its demand in the market.

Moreover, the extracts segment is expected to grow with the fastest CAGR during the forecast period. The growing demand for chlorella from functional food & supplement manufacturers and the presence of high levels of water-based nutrients, such as essential amino acids, vitamin A, B vitamins, iron, calcium, chlorophyll, lutein, and zeaxanthin, are some of the factors driving the growth of this segment.

Based on source, the chlorella pyrenoidosa or sorokiniana segment is expected to grow at the highest CAGR during the forecast period. The fast growth of this segment is primarily attributed to its ability to grow very quickly, higher concentration of some vitamins and amino acids, like choline, and higher protein content. Further, chlorella pyrenoidosa or sorokiniana potential to provide natural detoxification for immune support. Moreover, the chlorella vulgaris segment is expected to command a large share of the overall chlorella market in 2021. The large share of this market is mainly attributed to the growing demand for novel and natural flavored plant-based protein-rich ingredients and growing application in the biofuel industry.

Based on the application, the nutraceutical segment is expected to command the largest share of the overall chlorella market in 2021. The large share of this segment is primarily attributed to the properties and advantages of chlorella as an ideal health product that regulates immune effects and balances the body. In addition, chlorella extracts possess diverse antitumor, antioxidant, anti-inflammatory, and antimicrobial features, further driving the demand for chlorella in the nutraceuticals industry.

Advertisement
Stake.com

Europe is expected to grow at the highest CAGR during the forecast period. The fast growth of this region is primarily attributed to the rising demand for chlorella in cosmetic and personal care items; consumer’s willingness to pay higher prices for more natural, less processed, and environment-friendly products; and growing attraction among consumers for natural food products.

Key Players

The report includes a competitive landscape based on an extensive assessment of the key strategic developments adopted by the leading market participants in the chlorella market over the last four years (2018-2021). The key players operating in the global chlorella market are Flora Manufacturing & Distributing Ltd. (Canada), Roquette Klötze GmbH & Co. KG (Germany), Phycom (Netherlands), Tianjin Norland Biotech Co., Ltd. (China), Fuqing King Dnarmsa Spirulina Co. Ltd. (China), Far East Microalgae Industries, Co., Ltd.(FEMICO) (Taiwan), Allmicroalgae – Natural Products, S.A (Portugal), Qingdao Haizhijiao Biotechnology Co., Ltd. (China), STAUBER (U.S.), Alver World SA (Switzerland), AlgoSource (France), Taiwan Chlorella Manufacturing Company (Taiwan), E.I.D. – Parry (India) Limited (India), Dongtai City Spirulina Bio-engineering Co., Ltd. (China), Duplaco B.V. (The Netherlands), Sun Chlorella Corporation (Japan), Algorigin (Switzerland), Yunnan Green A Biological Project Co., Ltd (China), Zhejiang Comp Spirulina Co., Ltd. (China), Gong Bih Enterprise Co., Ltd. (China), and Wilson Group (Taiwan) among others.

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/chlorella-market-5162

Scope of the report

Advertisement
Stake.com

Chlorella Market, by Technology

  • Autotrophic
    • Open Pond
    • Closed Pond
  • Heterotrophic

Chlorella Market, by Product Type

  • Powder
  • Tablets
  • Extract
  • Capsules

Chlorella Market, by Source

  • Chlorella Vulgaris
  • Chlorella Pyrenoidosa or Sorokiniana
  • Others

Chlorella Market, by Application

  • Nutraceuticals
  • Food & Beverages
  • Animal Feed
  • Cosmetics
  • Others

Chlorella Market, by Sales/Distribution Channel

  • B2B
  • B2C
    • Offline
      • Distributors
      • Retailers
      • Direct-To-Consumer
    • Online

Chlorella Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of The Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East and Africa


Download Free Sample Report Now @ 
https://www.meticulousresearch.com/download-sample-report/cp_id=5162

     Amidst this crisis, Meticulous Research® is continuously assessing the impact of COVID-19 pandemic on various sub-markets and enables global organizations to strategize for the post-COVID-19 world and sustain their growth. Let us know if you would like to assess the impact of COVID-19 on any industry here- https://www.meticulousresearch.com/custom-research

Related Reports

  • Microalgae Market by Distribution Channel (Consumer Channel, Business Channel), Type (Spirulina, Chlorella, Dunaliella Salina, Haematococcus Pluvialis), Application (Nutraceuticals, Food & Beverage, Animal Feed, Cosmetics), and Geography—Global Forecast to 2028

https://www.meticulousresearch.com/product/microalgae-market-5197

  • Spirulina Market by Distribution Channel (Consumer Channel, Business Channel), Product Type (Powder, Tablets, Capsules, Flakes, Phycocyanin Extract), Application (Nutraceuticals, Food & Beverage, Agriculture, Animal Feed), and Geography—Global Forecast to 2028

https://www.meticulousresearch.com/product/spirulina-market-5070

  • Haematococcus Pluvialis Market by Product (Astaxanthin Ingredients [Oleoresin, Beadlet], Astaxanthin Bulk Finished Products [Capsules, Tablets]), Application (Food & Beverage, Nutraceuticals, Pharmaceuticals, Cosmetics), and Geography—Global Forecast to 2027

https://www.meticulousresearch.com/product/haematococcus-pluvialis-market-5142

  • Dunaliella Salina Market by End User (Extraction Companies, Food & Beverage Companies, Feed Companies, Nutraceutical & Health Supplement Companies, Pharmaceutical Companies, Cosmetics Companies) and Geography—Global Forecast to 2028

https://www.meticulousresearch.com/product/dunaliella-salina-market-5168

  • Phycocyanin Market by Form (Liquid, Powder), Grade (Food Grade, Cosmetics Grade, Reagent Grade, Analytical Grade), Application (Food & Beverage, Pharmaceuticals & Nutraceuticals, Diagnostics & Biomedical), and Geography—Global Forecast to 2027

https://www.meticulousresearch.com/product/phycocyanin-market-5126

  • Algal Pigments Market by Type (Beta Carotene, Astaxanthin, Fucoxanthin, Phycocyanin, Phycoerythrin), Application (Food & Beverage, Nutraceuticals, Aquaculture, Cosmetics, Pharmaceuticals), and Geography—Global Forecast to 2025

https://www.meticulousresearch.com/product/algal-pigments-market-5059

  • Algae Products Market by Value (Medium-value, High-value, Low-value), Product Type (Hydrocolloids, Carotenoids, Omega-3 PUFA, Spirulina, Chlorella), Application (Food & Feed, Nutraceuticals, Cosmetics, Chemicals), and Geography—Forecast 2022

https://www.meticulousresearch.com/product/algae-products-market-forecast-2022-3579

About Meticulous Research®

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Advertisement
Stake.com

The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Contact:
Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding, 
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- [email protected] 
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Content Source: https://www.meticulousresearch.com/pressrelease/374/chlorella-market-2028


GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

MGI Tech and SeqOne Partner to Advance End-to-end Genomic Analysis

Published

on

mgi-tech-and-seqone-partner-to-advance-end-to-end-genomic-analysis

PARIS, June 17, 2024 /PRNewswire/ — MGI (MGI Tech Co., Ltd. or its subsidiaries, together referred to MGI), a company committed to building core tools and technologies that drive innovation in life science, today announced the collaboration with SeqOne, a leading provider of AI-driven genomic decision support software, to develop and validate end-to-end genomic analysis solutions from sample to report tailored to the needs of Human Genetics and Pathology labs worldwide.

This collaboration between MGI and SeqOne encompasses three distinct initiatives:
Validating an end-to-end, automated, cost-effective solution for HRD signature with MGI DNBSEQ-G99
The collaboration between a Pathology Reference Lab in Spain, Agilent Technologies, MGI, and SeqOne aims to technically validate a routine workflow leveraging Agilent panels, Magnis lib prep automation, MGI DNBSEQ-G99, and SeqOne somaHRD, a clinically validated HRD signature solution, on 96 samples.
This end-to-end solution for pathology molecular labs will enable high-quality, efficient, and flexible HRD testing worldwide, including Genomic Instability score and BRCA testing.
Enabling and validating SeqOne tertiary analysis solution compatible with MGI Megabolt for Germline Panels, Whole Exome and Whole Genome
MegaBOLT bioinformatics analysis accelerator, self-developed and MPS-concentrated hardware accelerating system by MGI, is set to ensure seamless integration and compatibility with SeqOne’s AI-powered variants identification and analysis solution.
The collaboration aims to combine MegaBOLT and the SeqOne Platform to deliver a versatile, cost-effective, intuitive, and time-saving solution from sample to report, particularly attractive for high-throughput Human Genetics labs.
Validating SeqOne CE-IVD Platform for Germline and Somatic analysis for use with MGI sequencers in routine diagnostics
This technical validation project aims to evaluate the compatibility of the SeqOne Platform with MGI sequencing data. It will validate variant calling performances on a set of reference control samples in terms of QC, sensitivity and precision.
“We are thrilled to announce our collaboration with SeqOne. By combining MGI’s cutting-edge sequencing technology with SeqOne’s innovative genomic analysis Platform, we are poised to deliver real insights and solutions for personalized healthcare,” said Dr. Yong Hou, General Manager of MGI Europe and Africa. “This collaboration underscores our commitment to advancing genomic research and providing clinicians with the tools they need to offer tailored treatments to their patients.”
“This partnership with MGI strongly supports SeqOne’s mission to broaden access to sophisticated genomic analysis, aiming to improve healthcare outcomes,” said Martin Dubuc, CEO, SeqOne. “Molecular laboratories globally are exploring how MGI’s sequencing and bioinformatics technologies can advance next-generation sequencing (NGS) research and diagnostics. We are eager to integrate SeqOne’s CE-IVD Platform with MGI’s offerings, enhancing the quality, sensitivity, and precision of bioinformatic analyses.”
About MGI
MGI Tech Co., Ltd. (or its subsidiaries, together referred to MGI) is committed to building core tools and technologies that drive innovation in life science. Our focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. We provide real-time, multi-omics, and full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare and various other industries. Founded in 2016, MGI has grown into a leader in life science, serving customers across six continents and have established research, manufacturing, training, and after-sales service facilities globally. MGI stands out as one of the few companies capable of independently developing and mass-producing clinical-grade gene sequencers with varying throughput capacities, ranging from Gb to Tb levels. With unparalleled expertise, cutting-edge products, and a commitment to global impact, MGI continues to shape the trajectory of life sciences into the future. To learn more, please visit https://en.mgi-tech.com/, LinkedIn, X, and YouTube.
About SeqOne
SeqOne is a fast-growing deep-tech company focused on turning genomic data into medically- actionable insights in oncology and rare and inherited diseases. Our vision is to make personalized healthcare a reality for every patient, everywhere. We are committed to democratizing access to advanced genomic insights, enabling labs of any size, in any location, to offer affordable personalized medicine solutions to patients at scale. We integrate cutting-edge AI and big data technologies to redefine genetic data analysis. Our CE-IVD Platform provides time saving, flexible, and cost-effective decision support, empowering decentralized laboratories worldwide to deliver precision diagnostics.The company has won numerous awards, including the iLab award and the ARC Cancer Foundation’s Hélène Stark prize. Investors include Elaia, IRDI Capital Investissement, Merieux Equity Partners, Omnes, and Software Club. To learn more, please visit www.seqone.com and Linkedin.
Logo – https://mma.prnewswire.com/media/2329841/MGI__Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/mgi-tech-and-seqone-partner-to-advance-end-to-end-genomic-analysis-302173987.html

Continue Reading

Artificial Intelligence

Symphony Talent’s Award-Winning Full-Funnel Talent Acquisition Portfolio Earns Strategic Challenger Status on Fosway 9-Grid™ for Third Consecutive Year

Published

on

symphony-talent’s-award-winning-full-funnel-talent-acquisition-portfolio-earns-strategic-challenger-status-on-fosway-9-grid™-for-third-consecutive-year

NEW YORK and LONDON, June 17, 2024 /PRNewswire/ — Symphony Talent, a global leader in recruitment marketing technology and employer brand services, has been named a Strategic Challenger on the 2024 Fosway 9-Grid™ for Talent Acquisition for the third consecutive year, demonstrating Symphony Talent’s consistent dedication to providing cutting-edge solutions that drive game-changing results for talent acquisition teams worldwide.

“From rapidly evolving technologies to shifting candidate expectations, the TA industry faces many challenges,” says Sven Elbert, Head of Analyst Services at Fosway Group. “A full-funnel talent acquisition solution — that seamlessly aligns employer branding, technology and data analytics to the candidate journey — is essential to address these complexities. Symphony Talent provides a robust framework for meeting the diverse needs of complex, global enterprise-scale clients.”
Empowering TA Teams with Full-Funnel Solutions
Symphony Talent’s extensive portfolio of talent acquisition solutions, including its Brand and Creative Services, Programmatic Media Advertising, Career Sites, CRM, and Assessments, drive outstanding client results by addressing every stage of the talent acquisition funnel. Over 700 global clients leverage Symphony Talent’s innovative technologies and strategic expertise, achieving significant outcomes, such as:
Cutting administrative recruiting tasks by 65%Spending 70% less time managing media spendReducing time spent qualifying talent by 60%Decreasing cost per hire by 25%Filling open positions 30% fasterEnsuring quality hires with a 15% reduction in employee turnover”We are honored to be recognized as a Strategic Challenger on the Fosway 9-Grid™ for the third year in a row,” says Kermit Randa, CEO of Symphony Talent. “This achievement highlights our ongoing commitment to connect clients with innovative, high-impact solutions and data that empower them to navigate the complexities of today’s talent landscape and confidently convert candidates to co-workers.”
Highlights of Symphony Talent’s Achievement:
Innovation and Leadership: Symphony Talent’s continuous recognition as a Strategic Challenger is a testament to its unwavering commitment to innovation and leadership in the talent acquisition industry. The company’s comprehensive suite of solutions, including the award-winning SFX platform, integrates brand and creative services with recruitment marketing technology to streamline the hiring process and enhance candidate experience.Client-Centric Approach: Symphony Talent’s focus on understanding and addressing its clients’ evolving needs has been pivotal in maintaining its strategic position. Symphony Talent ensures clients achieve tangible and measurable outcomes by offering personalized support, detailed implementation schedules, and optimization workgroups.Adaptation to Market Trends: With a deep understanding of the current market dynamics and the challenges faced by talent acquisition teams, Symphony Talent has continuously adapted its offerings to meet these demands. This includes leveraging AI and automation to enhance productivity and providing data-driven insights to optimize recruitment strategies.About the Fosway 9-Grid™
Fosway Group is Europe’s #1 HR industry analyst. The Fosway 9-Grid™ provides a unique assessment of the principal learning and talent supply options available to organisations in EMEA. The analysis is based on extensive independent research and insights from Fosway’s Corporate Research Network of over 250 organisations, including BP, HSBC, PwC, RBS, Sanofi, Shell, and Vodafone. Visit the Fosway website at www.fosway.com.
About Symphony Talent
Symphony Talent is a recruitment marketing technology and employer brand services company that helps talent acquisition teams execute strategic, innovative candidate interactions. Our award-winning, synergistic technology and brand solutions are designed to deliver outcomes — from reach to retention — that unlock a competitive advantage for clients across the globe, including the world’s leading brands. Visit symphonytalent.com to learn more.
Logo – https://mma.prnewswire.com/media/2287879/ST_Logo_Single_Line_Full_Color__12_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/symphony-talents-award-winning-full-funnel-talent-acquisition-portfolio-earns-strategic-challenger-status-on-fosway-9-grid-for-third-consecutive-year-302173377.html

Continue Reading

Artificial Intelligence

Darwinbox named as a Customers’ Choice in the 2024 Gartner® Peer Insights™ Voice of the Customer for Cloud HCM Suites Report for Enterprises with 1,000+ Employees

Published

on

darwinbox-named-as-a-customers’-choice-in-the-2024-gartner-peer-insights™-voice-of-the-customer-for-cloud-hcm-suites-report-for-enterprises-with-1,000+-employees

DUBAI, UAE, June 17, 2024 /PRNewswire/ — Darwinbox, a global leader in cloud-based HCM solutions, today announced that it has been distinguished as a Customers’ Choice in the 2024 Gartner® Peer Insights™ Voice of the Customer for Cloud HCM Suites for 1,000+ Employee Enterprises.

The Gartner® Peer Insights™ Customers’ Choice distinction is based on feedback and ratings from end-user professionals with experience using the product or service. As of 31 January 2024, Darwinbox received an overall rating of 4.8 out of 5 stars across 141 reviews.
“We believe this distinction, for the third consecutive year, reflects our unwavering commitment to our customers and their success, as well as our dedication to excellence and innovation in the HCM space,” says Jayant Paleti, co-founder, Darwinbox.
Darwinbox has been named a Customers’ Choice for both Large Enterprise (1B – 10B USD) and Midsize Enterprise (50M – 1B USD) segments, showcasing its robust capabilities in handling large-scale operations and its widespread appeal across various business sizes. This recognition underscores the platform’s popularity, driven by its powerful configurability, intuitive design, and agility. An impressive 98% of customers rated Darwinbox 4-stars or higher, highlighting the overwhelming satisfaction with the product.
Furthermore, Darwinbox is recognized as the most customer-friendly enterprise-grade HCM solution globally. The platform distinguishes itself through its ease of implementation and integration, prompt vendor responses, and exceptional technical support, demonstrating Darwinbox’s dedication to quick service and client satisfaction. Notably, 94% of its customers have expressed their willingness to recommend Darwinbox, demonstrating its significant impact and reliability in the enterprise tech landscape.
“What I love is when we need support, the customer service is top-notch – always responsive, solution makers, and always helpful,” HR Business Partner, Media Industry
“Darwinbox has been able to cater to our needs given our diverse business structures and differences in processes,” HR Lead, Manufacturing Sector
Read more reviews
About Darwinbox:
Darwinbox is a leading SaaS-based HR technology platform, empowering organisations to automate HR processes and elevate the employee experience. Rated the highest globally among HCM players on Gartner’s customer review platform, Peer Insights, Darwinbox is trusted by 900+ global enterprises with more than 2.5 million employees spread across 116+ countries.
Photo: https://mma.prnewswire.com/media/2438686/Darwinbox_Voice_of_the_Customer.jpg

View original content:https://www.prnewswire.co.uk/news-releases/darwinbox-named-as-a-customers-choice-in-the-2024-gartner-peer-insights-voice-of-the-customer-for-cloud-hcm-suites-report-for-enterprises-with-1-000-employees-302173015.html

Continue Reading

Trending